These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7516319)

  • 1. Modification of metabolism of transplantable and spontaneous murine tumors by the nitric oxide synthase inhibitor, nitro-L-arginine.
    Wood PJ; Sansom JM; Stratford IJ; Adams GE; Szabo C; Thiemermann C; Vane JR
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):443-7. PubMed ID: 7516319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability.
    Wood PJ; Stratford IJ; Adams GE; Szabo C; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1993 Apr; 192(2):505-10. PubMed ID: 8484762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine.
    Wood PJ; Sansom JM; Butler SA; Stratford IJ; Cole SM; Szabo C; Thiemermann C; Adams GE
    Cancer Res; 1994 Dec; 54(24):6458-63. PubMed ID: 7987843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopy.
    Wood PJ; Stratford IJ; Sansom JM; Cattanach BM; Quinney RM; Adams GE
    Int J Radiat Oncol Biol Phys; 1992; 22(3):473-6. PubMed ID: 1735681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of a nitric oxide synthase inhibitor, N omega-nitro-L-arginine, and drug-induced increase in cerebellar cyclic GMP in vivo.
    Bansinath M; Arbabha B; Turndorf H; Garg UC
    Neurochem Res; 1993 Oct; 18(10):1063-6. PubMed ID: 7504789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.
    Butler SA; Wood PJ; Cole S; Williams C; Adams GE; Stratford IJ
    Br J Cancer; 1997; 76(4):438-44. PubMed ID: 9275019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective efficacy of N omega-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase.
    Carreau A; Duval D; Poignet H; Scatton B; Vigé X; Nowicki JP
    Eur J Pharmacol; 1994 May; 256(3):241-9. PubMed ID: 7519148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase in the pig autonomic nervous system in relation to the influence of NG--nitro-L-arginine on sympathetic and parasympathetic vascular control in vivo.
    Modin A; Weitzberg E; Hökfelt T; Lundberg JM
    Neuroscience; 1994 Sep; 62(1):189-203. PubMed ID: 7529378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice.
    Ohno M; Watanabe S
    Eur J Pharmacol; 1995 Feb; 275(1):39-44. PubMed ID: 7539765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central serotoninergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase.
    Squadrito F; Calapai G; Altavilla D; Cucinotta D; Zingarelli B; Arcoraci V; Campo GM; Caputi AP
    Eur J Pharmacol; 1994 Apr; 255(1-3):51-5. PubMed ID: 7517883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dose-related effects of nitric oxide synthase inhibition on cerebral blood flow during isoflurane and pentobarbital anesthesia.
    Todd MM; Wu B; Warner DS; Maktabi M
    Anesthesiology; 1994 May; 80(5):1128-36. PubMed ID: 7517107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of islet nitric oxide synthase increases arginine-induced insulin release.
    Panagiotidis G; Alm P; Lundquist I
    Eur J Pharmacol; 1992 Dec; 229(2-3):277-8. PubMed ID: 1283375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit.
    Holmquist F; Stief CG; Jonas U; Andersson KE
    Acta Physiol Scand; 1991 Nov; 143(3):299-304. PubMed ID: 1722938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle.
    French JF; Lambert LE; Dage RC
    J Pharmacol Exp Ther; 1991 Oct; 259(1):260-4. PubMed ID: 1717680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
    Orucevic A; Lala PK
    Br J Cancer; 1996 Jan; 73(2):189-96. PubMed ID: 8546905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs.
    Toda N; Kitamura Y; Okamura T
    Hypertension; 1993 Jan; 21(1):3-8. PubMed ID: 7678095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone rats.
    Izuta M; Clavier N; Kirsch JR; Traystman RJ
    Stroke; 1995 Jun; 26(6):1079-85. PubMed ID: 7539167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo radiation protection by nitric oxide modulation.
    Liebmann J; DeLuca AM; Coffin D; Keefer LK; Venzon D; Wink DA; Mitchell JB
    Cancer Res; 1994 Jul; 54(13):3365-8. PubMed ID: 7516820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
    J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta.
    Schini VB; Vanhoutte PM
    J Pharmacol Exp Ther; 1992 May; 261(2):553-9. PubMed ID: 1374468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.